EMAIL THIS PAGE TO A FRIEND

Biotechnology journal

Angiogenic/osteogenic response of BMMSCs on bone-derived scaffold: effect of hypoxia and role of PI3K/Akt-mediated VEGF-VEGFR pathway.


PMID 24421279

Abstract

Bone tissue deficiency is a common clinical challenge. Tissue-engineered bone constructs are an effective approach for the repair of orthopedic bone defects. Mimicking the essential components of the in vivo microenvironment is an efficient way to develop functional constructs. In this study, bone marrow-derived mesenchymal stromal cells (BMMSCs) were seeded into bone-derived scaffolds, a material with similar structure to natural bone. This was done under hypoxic conditions, an environment that imitates that experienced by BMMSCs in vivo. Our data indicate that hypoxia (5% O2 ) significantly increases the proliferation of BMMSCs seeded in scaffolds. As reflected by highly expressed osteogenesis- and angiogenesis-associated biomarkers, including vascular endothelial growth factor (VEGF), RUNX2, bone morphogenetic protein-2/4 and osteopontin, hypoxia also significantly increases the osteogenic and angiogenic responses of BMMSCs seeded into bone-derived scaffold composites. PI3K/Akt-mediated regulation of VEGF-activated VEGFR1/2 signaling is important for hypoxia-induced proliferative/osteogenic/angiogenic responses in BMMSC cellular scaffolds. The combination of bone-derived scaffolds and hypoxia is conducive to the differentiation of BMMSCs into functional tissue-engineered scaffold composites.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4300609
Anti-FLT4 antibody produced in rabbit, affinity isolated antibody
SAB4300356
Anti-KDR (Ab-1175) antibody produced in rabbit, affinity isolated antibody
SAB4300357
Anti-KDR (Ab-1214) antibody produced in rabbit, affinity isolated antibody
SAB4300358
Anti-KDR (Ab-951) antibody produced in rabbit, affinity isolated antibody
SAB2900238
Anti-KDR (AB1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2900239
Anti-KDR (AB2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2101239
Anti-KDR antibody produced in rabbit, affinity isolated antibody
V1014 Anti-Vascular Endothelial Growth Factor Receptor 2 antibody produced in goat, affinity isolated antibody, lyophilized powder
GW21181 Anti-VEGFR-2 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB4300657
Anti-VEGFR2 (Ab-1059) antibody produced in rabbit, affinity isolated antibody
SAB4501645
Anti-VEGFR2 antibody produced in rabbit, affinity isolated antibody
WH0002324M1
Monoclonal Anti-FLT4 antibody produced in mouse, clone 5B6, purified immunoglobulin, buffered aqueous solution
SAB1403833
Monoclonal Anti-FLT4 antibody produced in mouse, clone 5B5, purified immunoglobulin, buffered aqueous solution
SAB1409022
Monoclonal Anti-FLT4 antibody produced in mouse, clone 1C1, purified immunoglobulin, buffered aqueous solution
WH0003791M1
Monoclonal Anti-KDR antibody produced in mouse, clone 2A2, purified immunoglobulin, buffered aqueous solution
SAB1404004
Monoclonal Anti-KDR antibody produced in mouse, clone 4A2, purified immunoglobulin, buffered aqueous solution
V9134
Monoclonal Anti-Vascular Endothelial Growth Factor Receptor-2 antibody produced in mouse, clone KDR-1, ascites fluid
SAB1305566
MONOCLONAL ANTI-VEGFR3 antibody produced in mouse, clone 818CT12.1.1, IgG fraction of antiserum, buffered aqueous solution